Sign in

CIK 0001842295 · Non-accelerated filer<br>Emerging growth company

Maze Therapeutics, Inc.

Sign in to watch
Ticker
MAZE
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
6508505070
Business address
171 OYSTER POINT BOULEVARD, SUITE 300, SOUTH SAN FRANCISCO, CA, 94080
  1. 8-K Event Results of operations
  2. SCHEDULE 13G Stake Statement of Beneficial Ownership
  3. SCHEDULE 13G Stake Statement of Beneficial Ownership
  4. SCHEDULE 13G Stake Statement of Beneficial Ownership
  5. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  6. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  7. 10-K Report Annual Report
  8. 8-K Event Results of operations
  9. SCHEDULE 13G Stake Statement of Beneficial Ownership
  10. SCHEDULE 13G Stake Statement of Beneficial Ownership
  11. SCHEDULE 13G Stake Statement of Beneficial Ownership
  12. SCHEDULE 13G Stake Statement of Beneficial Ownership
  13. SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
  14. 4 Insider Changes in Ownership
  15. 4 Insider Changes in Ownership
  16. 4 Insider Changes in Ownership
  17. S-8 Other Securities Offered to Employees in Benefit Plans
  18. 424B4 Offering Prospectus
  19. EFFECT Other Notice of Effectiveness
  20. 3 Insider Initial Statement of Ownership

Page 9 of 12 · 224 filings